Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan —2012 Version
Tamio Teramoto,Jun Sasaki,Shun Ishibashi,Sadatoshi Birou,Hiroyuki Daida,Seitaro Dohi,Genshi Egusa,Takafumi Hiro,Kazuhiko Hirobe,Mami Iida,Shinji Kihara,Makoto Kinoshita,Chizuko Maruyama,Takao Ohta,Tomonori Okamura,Shizuya Yamashita,Masayuki Yokode,Koutaro Yokote +17 more
About:
This article is published in Journal of Atherosclerosis and Thrombosis.The article was published on 2013-01-01 and is currently open access. It has received 437 citations till now.read more
Citations
More filters
Journal ArticleDOI
A New Proposal for the Target Value for Home BP in Type 2 Diabetes Patients: The J-HOP Study.
TL;DR: The target levels of home-monitored blood pressure (BP) in patients with type 2 diabetes mellitus (T2DM) have not yet been established and Quadratic equations of the relationship between clinic/home systolic BP (SBP) and log-transformed UACR were used to determine the home BP value.
Journal ArticleDOI
Association of obesity with serum free fatty acid levels in individuals at different stages of prediabetes.
TL;DR: In this article, the associations of prediabetes categories and obesity with serum free fatty acid (FFA) levels and adipose tissue insulin resistance were investigated, and the duration of obesity-related impairment in lipolysis inhibition after glucose ingestion was prolonged in IFG plus IGT and diabetes.
Journal ArticleDOI
Patency with antiplatelet treatment after vascular access intervention therapy: a retrospective observational study
Tomohito Mizuno,Motonobu Nakamura,Nobuhiko Satoh,Hiroyuki Tsukada,Akihiko Matsumoto,Yoshifumi Hamasaki,Haruki Kume,Masaomi Nangaku +7 more
TL;DR: Administration of antiplatelet agents was associated with a significant reduction in VAF risk after VAIVT, and multivariate analysis revealed that anti platelet treatment wasassociated with a lower risk of VAF afterVAIVT.
Journal ArticleDOI
12-Week Effectiveness and Safety of Low-Density Lipoprotein Cholesterol-Lowering Therapy by Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition in Patients With Familial Hypercholesterolemia and Hypercholesterolemia - Data From a Real-World Observational Study of Evolocumab in Japan
Koutaro Yokote,Junya Ako,Kazuo Kitagawa,Hyoe Inomata,Toshihiko Sugioka,Keiko Asao,Yasuhiko Shinmura,Junichiro Shimauchi,Tamio Teramoto +8 more
TL;DR: Results suggest that patients receiving evolocumab treatment in the real-world setting were predominantly those with FH and HC in the secondary prevention group and LDL-C-lowering effectiveness was observed in FH (both HoFH and HeFH) and HC patients.
Journal ArticleDOI
Proneness to high blood lipid-related indices in female smokers.
TL;DR: In women, all of the four lipid-related indices tested were higher in smokers than in nonsmokers, and these associations were independent of alcohol drinking.
References
More filters
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National
William C. Taylor,Nigel Unwin +1 more
Journal ArticleDOI
Carotid-Artery Intima and Media Thickness as a Risk Factor for Myocardial Infarction and Stroke in Older Adults
Daniel H. O'Leary,Joseph F. Polak,Richard A. Kronmal,Teri A. Manolio,Gregory L. Burke,Sidney K. Wolfson +5 more
TL;DR: Increases in the thickness of the intima and media of the carotid artery, as measured noninvasively by ultrasonography, are directly associated with an increased risk of myocardial infarction and stroke in older adults without a history of cardiovascular disease.
Journal ArticleDOI
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)☆☆☆
Alberico L. Catapano,Zeljko Reiner,Guy De Backer,Ian D. Graham,Marja-Riitta Taskinen,Olov Wiklund,Stefan Agewall,Eduardo Alegria,M. John Chapman,Paul N. Durrington,Serap Erdine,Julian Halcox,Richard J. Hobbs,John Kjekshus,Pasquale Perrone Filardi,Gabriele Riccardi,Robert F. Storey,David R. Wood +17 more
TL;DR: These Joint ESC/European Atherosclerosis Society (EAS) guidelines on the management of dyslipidaemias are complementary to the guidelines on CVD prevention in clinical practice and address not only physicians but also specialists from lipid clinics or metabolic units who are dealing with dyslipIDAemias that are more difficult to classify and treat.
Journal ArticleDOI
ESC/EAS Guidelines for the management of dyslipidaemias
Alberico L. Catapano,Željko Reiner,Guy De Backer,Ian D. Graham,Marja-Riitta Taskinen,Olov Wiklund,Stefan Agewall,Eduardo Alegria,M. John Chapman,Paul N. Durrington,Serap Erdine,Julian Halcox,Richard J. Hobbs,John Kjekshus,Pasquale Perrone Filardi,Gabriele Riccardi,Robert F. Storey,David R. Wood +17 more
Journal ArticleDOI
Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study
W M Verschuren,David R. Jacobs,Bennie P. M. Bloemberg,Daan Kromhout,Alessandro Menotti,Christ Aravanis,Henry Blackburn,Ratko Buzina,Anastasios Dontas,Flaminio Fidanza +9 more
TL;DR: The large difference in absolute CHD mortality rates at a given cholesterol level, however, indicates that other factors, such as diet, that are typical for cultures with a low CHD risk are also important with respect to primary prevention.
Related Papers (5)
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)☆☆☆
Alberico L. Catapano,Zeljko Reiner,Guy De Backer,Ian D. Graham,Marja-Riitta Taskinen,Olov Wiklund,Stefan Agewall,Eduardo Alegria,M. John Chapman,Paul N. Durrington,Serap Erdine,Julian Halcox,Richard J. Hobbs,John Kjekshus,Pasquale Perrone Filardi,Gabriele Riccardi,Robert F. Storey,David R. Wood +17 more